43 completed. 43 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 43 | Completed 43 |
Follow Embolism: new trials by email Literature Review of Embolism trials Research Report on Embolism
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Catheter-directed Thrombolysis in Intermediate-high Risk Acute Pulmonary Embolism Thrombolytic, Standard anticoagulation - Pulmonary Embolism | Phase 4 | Completed | Faculty Hospital Kralovske Vinohrady | 558 | 2022-10-19 | 2026-11-06 |
| Ultrasound-facilitated, Catheter-directed, Thrombolysis in Intermediate-high Risk Pulmonary Embolism Anticoagulation with heparin, EkoSonicTM Endovascular System - Pulmonary Embolism | Phase 4 | Completed | Boston Scientific Corporation | 544 | 2021-08-02 | 2026-11-16 |
| Extended-Duration Low-Intensity Apixaban to Prevent Recurrence in High-Risk Patients With Provoked Venous Thromboembolism Apixaban 2.5 MG, Placebo oral tablet - Deep Vein Thrombosis, Pulmonary Embolism | Phase 4 | Completed | Brigham and Women's Hospital | 600 | 2021-03-01 | 2025-11-14 |
| Weight-Adjusted vs Fixed Low Doses of Low Molecular Weight Heparin For Venous Thromboembolism Prevention in COVID-19 Enoxaparin - COVID, Thrombosis | Phase 4 | Completed | Central Hospital, Nancy, France | 1000 | 2020-05-13 | 2023-08-07 |
| Direct Mechanical Thrombectomy Versus Bridging Therapy Trevo and or Merci devices for stent retreival, Penumbra system for stent aspiration, recombinant tissue plasminogen activator - Thrombectomy, Ischemic Stroke | Phase 4 | Completed | Alexandria University | 51 | 2019-07-01 | 2022-01-03 |
| Chemoprophylaxis Plus Early Ambulation Chemoprophylaxis with Low Molecular Weight Heparin (LMWH) - Pulmonary Embolism, Thoracic Surgery | Phase 4 | Completed | Shen Lei | 581 | 2017-08-08 | 2021-11-02 |
| Comparative Effectiveness of Pulmonary Embolism Prevention After Hip and Knee Replacement Enteric Coated Aspirin, Warfarin, Rivaroxaban - Pulmonary Embolism, Venous Thrombosis | Phase 4 | Completed | Dartmouth-Hitchcock Medical Center | 18883 | 2016-12-01 | 2026-10-05 |
| : Pharmacokinetics of Enoxaparin After Coronary Artery Bypass Graft Surgery Enoxaparin - Venous Thromboembolism, Pulmonary Embolism | Phase 4 | Completed | Tampere University Hospital | 85 | 2016-05-01 | 2023-05-09 |
| Diuretic Vascular Filling in the Initial Management of Acute PE With Right Ventricular Dysfunction Normotensive Furosemide, NaCl 9% isotonic - Pulmonary Embolism | Phase 4 | Completed | Centre Hospitalier Universitaire de Nice | 60 | 2015-12-23 | 2020-09-25 |
| Apixaban for the Acute Treatment of Venous Thromboembolism in Children Apixaban, Standard of Care - Venous Thromboembolism | Phase 4 | Completed | Bristol-Myers Squibb | 229 | 2015-11-22 | 2024-10-29 |
| A Study of Rivaroxaban for Early Discharge of Low Risk Pulmonary Embolism From the Emergency Department Rivaroxaban, Standard-of-care - Pulmonary Embolism | Phase 4 | Completed | Janssen Scientific Affairs, LLC | 114 | 2015-10-15 | 2018-06-01 |
| Optimum Duration of Acoustic Pulse Thrombolysis Procedure in Acute Pulmonary Embolism Ekosonic® Endovascular Device ultrasonic infusion catheter, Recombinant tissue plasminogen activator - Pulmonary Embolism and Thrombosis | Phase 4 | Completed | Boston Scientific Corporation | 131 | 2015-06-12 | 2021-07-19 |
| NAC, NaHCO3 and NS Prophylaxis for CTPA in the ED on Suspicion of PE: A Randomized Controlled Trial NAC, NaHCO3, Normal Saline - Radiographic Contrast Agent Nephropathy, Pulmonary Embolism | Phase 4 | Completed | Karadeniz Technical University | 231 | 2014-02-01 | 2015-06-26 |
| Rivaroxaban Compared to Vitamin K Antagonist Upon Development of Cardiovascular Calcification Rivaroxaban or Marcumar - Atrial Fibrillation or Pulmonary Embolism, Need of Long Term Oral Anticoagulation Therapy (OAT) | Phase 4 | Completed | RWTH Aachen University | 192 | 2013-07-01 | 2020-10-22 |
| Vascular CalcIfiCation and sTiffness Induced by ORal antIcoAgulation Rivaroxaban, Fluindione, Warfarin - Permanent Atrial Fibrillation, Venous Thrombosis | Phase 4 | Completed | University Hospital, Angers | 51 | 2013-05-21 | 2019-11-07 |
| Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in Pregnancy Low dose nadroparin, Intermediate dose nadroparin, Low dose enoxaparin - Deep Venous Thrombosis, Pulmonary Embolism | Phase 4 | Completed | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 1110 | 2013-04-24 | 2022-05-26 |
| Venous Thromboembolic Prophylaxis After Trauma: Three Times a Day Unfractionated Heparin Versus Twice a Day Enoxaparin 5000 Units unfractionated Heparin Q 8 hr, 30mg enoxaparin Q12 hr - Venous Thromboembolic Disease, Deep Vein Thrombosis | Phase 4 | Completed | Scripps Health | 495 | 2012-11-01 | 2016-07-18 |
| Comparison of Thrombgolytic and Anticoagulation Therapy in Submassive Pulmonary Embolism Actilyse (Thrombolytic therapy), Heparine (Standard anticoagulation therapy) - Pulmonary Embolism | Phase 4 | Completed | University Hospital Ostrava | 100 | 2011-03-01 | 2018-03-19 |
| Efficacy of Low Molecular Weight Heparin in Superficial Vein Thrombosis Dalteparin - Superficial Thrombophlebitis | Phase 4 | Completed | University Medical Centre Ljubljana | 68 | 2010-12-01 | 2018-05-04 |
| Age-adjusted D-dimer Cut-off Levels to Rule Out Pulmonary Embolism Evaluation of a modified DD cut-off to rule out PE - Pulmonary Embolism | Phase 4 | Completed | Marc Righini | 3306 | 2010-10-01 | 2015-05-28 |
Showing 20 of 43. Sign in to see all of them.
Pulmonary Embolism (39) · Venous Thrombosis (15) · Thrombosis (8) · Venous Thromboembolism (8) · Atrial Fibrillation (5) · Thromboembolism (4) · Ischemic Stroke (2) · Stroke (2) · Antiphospholipid Syndrome (1) · Hematoma (1) · Hemorrhage (1) · Ischemia (1) · Lung Neoplasms (1) · Pancreatic Neoplasms (1)
Cardiovascular Diseases (43) · Embolism and Thrombosis (43) · Vascular Diseases (42) · Lung Diseases (39) · Respiratory Tract Diseases (39) · Thrombosis (13) · Pathologic Processes (9) · Pathological Conditions, Signs and Symptoms (9) · Thromboembolism (7) · Heart Diseases (6) · Arrhythmias, Cardiac (5) · Brain Diseases (3) · Central Nervous System Diseases (3) · Cerebrovascular Disorders (3)
Dalteparin (5) · Heparin, Low-Molecular-Weight (5) · Enoxaparin (4) · Rivaroxaban (4) · Tissue Plasminogen Activator (4) · Heparin (3) · Nadroparin (3) · Tinzaparin (3) · Warfarin (3) · Acetylcysteine (2) · Aspirin (2) · Fibrinolytic Agents (2) · Phenprocoumon (2) · Standard of Care (2) · Urokinase-Type Plasminogen Activator (2)
Beijing Chao Yang Hospital (4) · Boston Scientific Corporation (2) · Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) (1) · Alexandria University (1) · Assistance Publique - Hôpitaux de Paris (1) · Azienda Ospedaliera Universitaria Policlinico (1) · Bracco Diagnostics, Inc (1) · Brigham and Women's Hospital (1) · Bristol-Myers Squibb (1) · British Thoracic Society (1) · Cantonal Hospital of St. Gallen (1) · Central Hospital, Nancy, France (1) · Centre Hospitalier Universitaire de Nice (1) · Centre Hospitalier Universitaire de Saint Etienne (1) · Complejo Hospitalario Xeral-Calde (1)
United States (12) · France (10) · China (5) · Canada (4) · Germany (4) · Netherlands (4) · Spain (4) · United Kingdom (4) · Austria (3) · Switzerland (3) · Czechia (2) · Finland (2) · Ireland (2) · Russia (2) · Turkey (Türkiye) (2)
Alejandro Veres Racamonde, MD (1) · Aziz Sheikh, MD,FRCGP (1) · Bob Smouse, MD (1) · Carol A Lambourne, PhD (1) · Christopher J. Destache, Pharm. D. (1) · Dean T Yamaguchi, MD, PhD (1) · El Mehdi Siaghy (1) · Gening Jiang (1)
PMID 17065639, PMID 17289685, PMID 18656008, PMID 19741062, PMID 20040086, PMID 20352167, PMID 20353588, PMID 20553388, PMID 23299853, PMID 23306310, PMID 24135533, PMID 24643601, PMID 24768093, PMID 24807875, PMID 24876082, PMID 25900749, PMID 25903529, PMID 25919526, PMID 27411777, PMID 30025734, PMID 31926776, PMID 33337539, PMID 33502773, PMID 33779986, PMID 34622445, PMID 34878173, PMID 35244208, PMID 35381867, PMID 35588898, PMID 36303136, PMID 36354038, PMID 36695396, PMID 37350990, PMID 37977307, PMID 40888734, PMID 41910345, PMID 42392108, PMID 42678032
2014 (1), 2016 (1)